How Big Is the Hepatic Encephalopathy Market | Segmentation & Forecast 2031

Q: What is the current size of the hepatic encephalopathy market?

The hepatic encephalopathy market was valued at USD 0.85 Billion in 2024 and is expected to reach USD 1.26 Billion by 2031,

Q: What is the growth rate of the hepatic encephalopathy market?

The market is expected to grow at a CAGR of 6.9% between 2025 and 2031.

Q: What factors are driving the demand for hepatic encephalopathy treatments?

Key drivers include rising liver cirrhosis cases, increasing prevalence of hepatitis infections, and growing awareness about neurological liver disorders.

Q: Which treatment types are commonly used in hepatic encephalopathy?

Lactulose, rifaximin, and probiotics are widely prescribed, along with supportive nutritional and hospital care.

Q: What are the major challenges in the hepatic encephalopathy market?

Challenges include underdiagnosis in early stages, limited access to advanced treatment in rural areas, and high cost of branded medications.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6145

Publication Date: Jul 2025

How big is the Hepatic Encephalopathy Market?

According to 6Wresearch internal database and industry insights, the Global Hepatic Encephalopathy Market was valued at USD 0.85 Billion in 2024 and is expected to reach USD 1.26 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).

This growth is driven by increasing prevalence of liver diseases, rising awareness about early diagnosis, and improved access to treatment therapies.

View Main Report

Schedule Analyst Call

Key Growth Drivers of the Hepatic Encephalopathy Market

Rising incidence of chronic liver diseases like cirrhosis
Advancements in hepatic disorder diagnostics and therapeutics
Government initiatives to promote liver health awareness
Launch of novel drugs and treatment combinations
Growth in liver transplantation and post-operative care

Hepatic Encephalopathy Market Trends

Hepatic encephalopathy market is expanding steadily with increasing demand for early detection and efficient treatment of liver-related neurocognitive disorders. Oral therapies and lactulose-based treatments remain widely adopted, while rifaximin is gaining traction due to its effectiveness. Non-invasive diagnostic tools and hospital-based management protocols are improving patient care. There is also growing focus on managing covert HE through routine screenings and outpatient treatment.

Emerging Developments in the Hepatic Encephalopathy Market

Emerging developments include innovations in biomarkers for earlier and more accurate diagnosis. Companies are investing in developing second-generation therapeutics with fewer side effects and better patient compliance. Digital health tools like AI-assisted liver monitoring and remote patient tracking are enhancing chronic liver disease management. Research into microbiome-focused therapies and gut-liver axis modulation also offers promising future opportunities.